These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 4200537)

  • 1. Rubella immunization of volunteers via the respiratory tract.
    Ganguly R; Ogra PL; Regas S; Waldman RH
    Infect Immun; 1973 Oct; 8(4):497-502. PubMed ID: 4200537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specific immunoglobulin responses in serum and nasal secretions after the administration of attenuated rubella vaccine.
    Cradock-Watson JE; Macdonald H; Ridehalgh MK; Bourne MS; Vandervelde EM
    J Hyg (Lond); 1974 Aug; 73(1):127-41. PubMed ID: 4608331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The sequential appearance of antibody and immunoglobins in nasal secretion after immunization of volunteers with live and inactivated influenza B virus vaccines.
    Downie JC
    J Hyg (Lond); 1973 Sep; 71(3):433-45. PubMed ID: 4518342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serologic response to revaccination with two rubella vaccines.
    Brandling-Bennett AD; Jackson RS; Halstead SB; Campbell CC; Herrmann KL; Modlin JF; Meyers JD; Witte JJ
    Am J Dis Child; 1976 Oct; 130(10):1081-4. PubMed ID: 973610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mucosal IgA responses in healthy adult volunteers following intranasal spray delivery of a live attenuated measles vaccine.
    Simon JK; Ramirez K; Cuberos L; Campbell JD; Viret JF; Muñoz A; Lagos R; Levine MM; Pasetti MF
    Clin Vaccine Immunol; 2011 Mar; 18(3):355-61. PubMed ID: 21228137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rubella-specific serum and nasopharyngeal antibodies in volunteers with naturally acquired and vaccine-induced immunity after intranasal challenge.
    Harcourt GC; Best JM; Banatvala JE
    J Infect Dis; 1980 Aug; 142(2):145-55. PubMed ID: 7410897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunity following intranasal administration of an inactivated, freeze-dried A/England/42/72 vaccine.
    Potter CW; Jennings R; McLaren C; Clarke A
    Arch Virol; 1975; 48(4):307-16. PubMed ID: 1200844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccination by non-parenteral routes: characteristics of immune response.
    Ogra PL; Chiba Y; Beutner KR; Morag A
    Dev Biol Stand; 1976; 33():19-26. PubMed ID: 782968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral spray immunization may be an alternative to intranasal vaccine delivery to induce systemic antibodies but not nasal mucosal or cellular immunity.
    Bakke H; Samdal HH; Holst J; Oftung F; Haugen IL; Kristoffersen AC; Haugan A; Janakova L; Korsvold GE; Krogh G; Andersen EA; Djupesland P; Holand T; Rappuoli R; Haneberg B
    Scand J Immunol; 2006 Mar; 63(3):223-31. PubMed ID: 16499576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intranasal versus subcutaneous rubella vaccination in schoolgirls.
    Midulla M; Assensio AM; Balducci L; Vanni O; Msstropasqua S
    Dev Biol Stand; 1976; 33():241-8. PubMed ID: 955270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of the secretory immune system in protection against agents which infect the respiratory tract.
    Waldman RH; Ganguly R
    Adv Exp Med Biol; 1974; 45(0):283-94. PubMed ID: 4370501
    [No Abstract]   [Full Text] [Related]  

  • 12. Antibody response in serum and nasopharynx after naturally acquired and vaccine-induced infection with rubella virus.
    Ogra PL; Kerr-Grant D; Umana G; Dzierba J; Weintraub D
    N Engl J Med; 1971 Dec; 285(24):1333-9. PubMed ID: 4107718
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunity against parainfluenza-3 virus in cattle: anti-neuraminidase activity in serum and nasal secretion.
    Morein B; Höglund S; Bergman R
    Infect Immun; 1973 Oct; 8(4):650-6. PubMed ID: 4355138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attenuated influenza A vaccine (Alice) in an adult population: vaccine-related illness, serum and nasal antibody production, and intrafamily transmission.
    Minor TE; Dick EC; Dick CR; Inhorn SL
    J Clin Microbiol; 1975 Nov; 2(5):403-9. PubMed ID: 1104655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized trial demonstrating successful boosting responses following simultaneous aerosols of measles and rubella (MR) vaccines in school age children.
    Sepúlveda-Amor J; Valdespino-Gómez JL; García-García Mde L; Bennett J; Islas-Romero R; Echaniz-Aviles G; de Castro JF
    Vaccine; 2002 Jun; 20(21-22):2790-5. PubMed ID: 12034106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rubella virus immunization of preschool children via the respiratory tract.
    Ganguly R; Durrer B; Waldman RH
    Am J Dis Child; 1974 Dec; 128(6):821-3. PubMed ID: 4440651
    [No Abstract]   [Full Text] [Related]  

  • 17. Intranasal administration of RA 27/3 rubella virus vaccine. A clinical trial in young adults.
    Paradise JE; Nemorofsky D; Huggins GR; Sondheimer SJ; Plotkin SA
    J Adolesc Health Care; 1984 Apr; 5(2):75-8. PubMed ID: 6368506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Humoral and secretory antibody responses to immunization with low and high dosage split influenza virus vaccine.
    Ruben FL; Potter CW; Stuart-Harris CH
    Arch Virol; 1975; 47(2):157-66. PubMed ID: 1119940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunity to intranasal challenge with Rubella virus two years after vaccination: comparison of three vaccines.
    Grillner L
    J Infect Dis; 1976 Jun; 133(6):637-41. PubMed ID: 932491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of immunization against rubella on lactation products. I. Development and characterization of specific immunologic reactivity in breast milk.
    Losonsky GA; Fishaut JM; Strussenberg J; Ogra PL
    J Infect Dis; 1982 May; 145(5):654-60. PubMed ID: 7077089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.